In 2023, there were more than *** incidents of data compromises in the healthcare sector in the United States. Reaching its all-time highest. This indicates a significant growth since 2005 when the industry saw only ** cases of data compromises in the country.

Context

Part of Janatahack Hackathon in Analytics Vidhya

Content

The healthcare sector has long been an early adopter of and benefited greatly from technological advances. These days, machine learning plays a key role in many health-related realms, including the development of new medical procedures, the handling of patient data, health camps and records, and the treatment of chronic diseases.

MedCamp organizes health camps in several cities with low work life balance. They reach out to working people and ask them to register for these health camps. For those who attend, MedCamp provides them facility to undergo health checks or increase awareness by visiting various stalls (depending on the format of camp).

MedCamp has conducted 65 such events over a period of 4 years and they see a high drop off between “Registration” and number of people taking tests at the Camps. In last 4 years, they have stored data of ~110,000 registrations they have done.

One of the huge costs in arranging these camps is the amount of inventory you need to carry. If you carry more than required inventory, you incur unnecessarily high costs. On the other hand, if you carry less than required inventory for conducting these medical checks, people end up having bad experience.

The Process:

MedCamp employees / volunteers reach out to people and drive registrations.
During the camp, People who “ShowUp” either undergo the medical tests or visit stalls depending on the format of health camp.

Other things to note:

Since this is a completely voluntary activity for the working professionals, MedCamp usually has little profile information about these people.
For a few camps, there was hardware failure, so some information about date and time of registration is lost.
MedCamp runs 3 formats of these camps. The first and second format provides people with an instantaneous health score. The third format provides  
information about several health issues through various awareness stalls.

Favorable outcome:

For the first 2 formats, a favourable outcome is defined as getting a health_score, while in the third format it is defined as visiting at least a stall.
You need to predict the chances (probability) of having a favourable outcome.

Train / Test split:

Camps started on or before 31st March 2006 are considered in Train
Test data is for all camps conducted on or after 1st April 2006.

Acknowledgements

Credits to AV

Inspiration

To share with the data science community to jump start their journey in Healthcare Analytics

Between January and September 2024, healthcare organizations in the United States saw 491 large-scale data breaches, resulting in the loss of over 500 records. This figure has increased significantly in the last decade. To date, the highest number of large-scale data breaches in the U.S. healthcare sector was recorded in 2023, with a reported 745 cases.

Big Data Analytics In Healthcare Market size is estimated at USD 37.22 Billion in 2024 and is projected to reach USD 74.82 Billion by 2032, growing at a CAGR of 9.12% from 2026 to 2032.

Big Data Analytics In Healthcare Market: Definition/ Overview

Big Data Analytics in Healthcare, often referred to as health analytics, is the process of collecting, analyzing, and interpreting large volumes of complex health-related data to derive meaningful insights that can enhance healthcare delivery and decision-making. This field encompasses various data types, including electronic health records (EHRs), genomic data, and real-time patient information, allowing healthcare providers to identify patterns, predict outcomes, and improve patient care.

BackgroundThere is widespread evidence that statistical methods play an important role in original research articles, especially in medical research. The evaluation of statistical methods and reporting in journals suffers from a lack of standardized methods for assessing the use of statistics. The objective of this study was to develop and evaluate an instrument to assess the statistical intensity in research articles in a standardized way.MethodsA checklist-type measure scale was developed by selecting and refining items from previous reports about the statistical contents of medical journal articles and from published guidelines for statistical reporting. A total of 840 original medical research articles that were published between 2007–2015 in 16 journals were evaluated to test the scoring instrument. The total sum of all items was used to assess the intensity between sub-fields and journals. Inter-rater agreement was examined using a random sample of 40 articles. Four raters read and evaluated the selected articles using the developed instrument.ResultsThe scale consisted of 66 items. The total summary score adequately discriminated between research articles according to their study design characteristics. The new instrument could also discriminate between journals according to their statistical intensity. The inter-observer agreement measured by the ICC was 0.88 between all four raters. Individual item analysis showed very high agreement between the rater pairs, the percentage agreement ranged from 91.7% to 95.2%.ConclusionsA reliable and applicable instrument for evaluating the statistical intensity in research papers was developed. It is a helpful tool for comparing the statistical intensity between sub-fields and journals. The novel instrument may be applied in manuscript peer review to identify papers in need of additional statistical review.

Update — December 7, 2014. – Evidence-based medicine (EBM) is not working for many reasons, for example: 1. Incorrect in their foundations (paradox): hierarchical levels of evidence are supported by opinions (i.e., lowest strength of evidence according to EBM) instead of real data collected from different types of study designs (i.e., evidence). http://dx.doi.org/10.6084/m9.figshare.1122534 2. The effect of criminal practices by pharmaceutical companies is only possible because of the complicity of others: healthcare systems, professional associations, governmental and academic institutions. Pharmaceutical companies also corrupt at the personal level, politicians and political parties are on their payroll, medical professionals seduced by different types of gifts in exchange of prescriptions (i.e., bribery) which very likely results in patients not receiving the proper treatment for their disease, many times there is no such thing: healthy persons not needing pharmacological treatments of any kind are constantly misdiagnosed and treated with unnecessary drugs. Some medical professionals are converted in K.O.L. which is only a puppet appearing on stage to spread lies to their peers, a person supposedly trained to improve the well-being of others, now deceits on behalf of pharmaceutical companies. Probably the saddest thing is that many honest doctors are being misled by these lies created by the rules of pharmaceutical marketing instead of scientific, medical, and ethical principles. Interpretation of EBM in this context was not anticipated by their creators. “The main reason we take so many drugs is that drug companies don’t sell drugs, they sell lies about drugs.” ―Peter C. Gøtzsche “doctors and their organisations should recognise that it is unethical to receive money that has been earned in part through crimes that have harmed those people whose interests doctors are expected to take care of. Many crimes would be impossible to carry out if doctors weren’t willing to participate in them.” —Peter C Gøtzsche, The BMJ, 2012, Big pharma often commits corporate crime, and this must be stopped. Pending (Colombia): Health Promoter Entities (In Spanish: EPS ―Empresas Promotoras de Salud).

1. Misinterpretations New technologies or concepts are difficult to understand in the beginning, it doesn’t matter their simplicity, we need to get used to new tools aimed to improve our professional practice. Probably the best explanation is here in these videos (credits to Antonio Villafaina for sharing these videos with me). English https://www.youtube.com/watch?v=pQHX-SjgQvQ&w=420&h=315 Spanish https://www.youtube.com/watch?v=DApozQBrlhU&w=420&h=315 ----------------------- Hypothesis: hierarchical levels of evidence based medicine are wrong Dear Editor, I have data to support the hypothesis described in the title of this letter. Before rejecting the null hypothesis I would like to ask the following open question:Could you support with data that hierarchical levels of evidence based medicine are correct? (1,2) Additional explanation to this question: – Only respond to this question attaching publicly available raw data.– Be aware that more than a question this is a challenge: I have data (i.e., evidence) which is contrary to classic (i.e., McMaster) or current (i.e., Oxford) hierarchical levels of evidence based medicine. An important part of this data (but not all) is publicly available. References
2. Ramirez, Jorge H (2014): The EBM challenge. figshare. http://dx.doi.org/10.6084/m9.figshare.1135873
3. The EBM Challenge Day 1: No Answers. Competing interests: I endorse the principles of open data in human biomedical research Read this letter on The BMJ – August 13, 2014.http://www.bmj.com/content/348/bmj.g3725/rr/762595Re: Greenhalgh T, et al. Evidence based medicine: a movement in crisis? BMJ 2014; 348: g3725. _ Fileset contents Raw data: Excel archive: Raw data, interactive figures, and PubMed search terms. Google Spreadsheet is also available (URL below the article description). Figure 1. Unadjusted (Fig 1A) and adjusted (Fig 1B) PubMed publication trends (01/01/1992 to 30/06/2014). Figure 2. Adjusted PubMed publication trends (07/01/2008 to 29/06/2014) Figure 3. Google search trends: Jan 2004 to Jun 2014 / 1-week periods. Figure 4. PubMed publication trends (1962-2013) systematic reviews and meta-analysis, clinical trials, and observational studies.
   Figure 5. Ramirez, Jorge H (2014): Infographics: Unpublished US phase 3 clinical trials (2002-2014) completed before Jan 2011 = 50.8%. figshare.http://dx.doi.org/10.6084/m9.figshare.1121675 Raw data: "13377 studies found for: Completed | Interventional Studies | Phase 3 | received from 01/01/2002 to 01/01/2014 | Worldwide". This database complies with the terms and conditions of ClinicalTrials.gov: http://clinicaltrials.gov/ct2/about-site/terms-conditions Supplementary Figures (S1-S6). PubMed publication delay in the indexation processes does not explain the descending trends in the scientific output of evidence-based medicine. Acknowledgments I would like to acknowledge the following persons for providing valuable concepts in data visualization and infographics:
4. Maria Fernanda Ramírez. Professor of graphic design. Universidad del Valle. Cali, Colombia.
5. Lorena Franco. Graphic design student. Universidad del Valle. Cali, Colombia. Related articles by this author (Jorge H. Ramírez)
6. Ramirez JH. Lack of transparency in clinical trials: a call for action. Colomb Med (Cali) 2013;44(4):243-6. URL: http://www.ncbi.nlm.nih.gov/pubmed/24892242
7. Ramirez JH. Re: Evidence based medicine is broken (17 June 2014). http://www.bmj.com/node/759181
8. Ramirez JH. Re: Global rules for global health: why we need an independent, impartial WHO (19 June 2014). http://www.bmj.com/node/759151
9. Ramirez JH. PubMed publication trends (1992 to 2014): evidence based medicine and clinical practice guidelines (04 July 2014). http://www.bmj.com/content/348/bmj.g3725/rr/759895 Recommended articles
10. Greenhalgh Trisha, Howick Jeremy,Maskrey Neal. Evidence based medicine: a movement in crisis? BMJ 2014;348:g3725
11. Spence Des. Evidence based medicine is broken BMJ 2014; 348:g22
12. Schünemann Holger J, Oxman Andrew D,Brozek Jan, Glasziou Paul, JaeschkeRoman, Vist Gunn E et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies BMJ 2008; 336:1106
13. Lau Joseph, Ioannidis John P A, TerrinNorma, Schmid Christopher H, OlkinIngram. The case of the misleading funnel plot BMJ 2006; 333:597
14. Moynihan R, Henry D, Moons KGM (2014) Using Evidence to Combat Overdiagnosis and Overtreatment: Evaluating Treatments, Tests, and Disease Definitions in the Time of Too Much. PLoS Med 11(7): e1001655. doi:10.1371/journal.pmed.1001655
15. Katz D. A-holistic view of evidence based medicinehttp://thehealthcareblog.com/blog/2014/05/02/a-holistic-view-of-evidence-based-medicine/ ---

Introduction

Medical Technology and Innovation Statistics: In recent years, there has been a remarkable acceleration in the pace of medical technology advancements. These are driven by factors such as technological advancements, increased funding for research and development, and the growing demand for innovative solutions to address healthcare challenges.

These advancements have the potential to revolutionize various aspects of healthcare delivery, from diagnostics and treatment to patient monitoring and disease prevention.

Snapshot img

Healthcare Analytics Market Size 2025-2029

The healthcare analytics market size is forecast to increase by USD 81.28 billion, at a CAGR of 25% between 2024 and 2029.

The market is experiencing significant growth due to several key trends. The integration of big data with healthcare analytics is a major growth factor, enabling healthcare providers to make data-driven decisions and improve patient outcomes.
Another trend is the increasing use of Internet-enabled mobile devices in healthcare services, allowing for remote monitoring and real-time data access. However, data security and privacy concerns remain a challenge, with the need for strong security measures to protect sensitive patient information. These trends are shaping the future of patient engagement and driving growth in the global healthcare analytics market as well.

What will be the Size of the Healthcare Analytics Market During the Forecast Period?

Request Free Sample

The market is experiencing significant growth due to the increasing adoption of digital solutions for improving patient care and reducing treatment costs. Healthcare organizations are leveraging descriptive analytics to gain insights from clinical data, while predictive and prescriptive analytics enable the development of personalized treatment plans and optimal therapeutic strategies. Financial analytics help manage healthcare expenses, ensuring cost-effective patient care. The National Institutes of Health (NIH) and other research institutions are driving innovation in health data analytics, leading to advancements in areas such as patient compliance, medication selection, and disease management. Industry leaders are utilizing artificial intelligence and machine learning to enhance clinical care, outreach, and disease management, ultimately leading to better treatment consistency and optimal outcomes for patients.

How is this Healthcare Analytics Industry segmented and which is the largest segment?

The healthcare analytics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Component

  Services
  Software
  Hardware


Deployment

  On-premise
  Cloud-based


Type

  Descriptive Analysis
  Predictive Analysis
  Prescriptive and Diagnostics


Application

  Financial Analytics
  Clinical Analytics
  Operations and Administrative Analytics
  Population Health Analytics


End-User

  Insurance Company
  Government Agencies
  Healthcare Providers
  Pharmaceutical and Medical Device Companies


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan
    South Korea


  South America



  Middle East and Africa

By Component Insights

The services segment is estimated to witness significant growth during the forecast period. Healthcare analytics services encompass consulting, learning and training, development and integration, hardware maintenance and support, IT management, process management, and software support. The consulting and software support segments are experiencing significant growth due to the increasing demand for advanced healthcare delivery systems and cost-effective models. The healthcare sector's ongoing transition from on-premises to cloud-based software and IT infrastructure deployment is another growth driver. This shift is expected to increase the demand for IT education and training services. End-users of these services range from individual doctor offices to full-service hospitals and multi-location clinics, including large hospitals and tissue and blood processing organizations.

Get a glance at the share of various segments. Request Free Sample

The services segment was valued at USD 6.7 billion in 2019 and showed a gradual increase during the forecast period.

Regional Analysis

APAC is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The North American market is driven by the increasing demand for secure data access and effective patient information management. The US and Canada are the primary contributors to this market due to their early adoption of advanced technologies, such as machine learning, predictive analytics, and quantum computing, across various industries. These technologies enable the healthcare sector to optimize patient compliance, medication selection, and therapeutic strategies and, ultimately, achieve optimal outcomes. Major companies in this market provide solutions to help healthcare organizations manage and

In 2023, the top prioritized reskilling skill focus in the medical and healthcare services sector worldwide by companies was creative thinking, with ** percent of respondents who stated this as their answer. ** percent of respondents stated design and user experience was their top priority in reskilling the medical and healthcare services sector.

The size of the US Health Information Exchange Industry market was valued at USD 0.66 Million in 2023 and is projected to reach USD 1.47 Million by 2032, with an expected CAGR of 12.12% during the forecast period. The U.S. HIE market has been enjoying a robust growth trajectory for years now and has received substantial impetus due to the requirements to improve care and outcome, occasioned by rising demand for healthcare providers to have their requirements of liquid sharing of data. HIE enables the electronic exchange of health information across various organizations and systems. This enables them to have broad access to patient information by healthcare professionals and reduces redundancies while enhancing care coordination. Key drivers in the market are driven by governments pushing interoperability and the use of EHRs seen within the 21st Century Cures Act, underlining the improvement of shared data. More attention is paid to value-based care models and population health management for health providers involved in better decision-making and improving patient care through HIE solutions. The geographic regions further illustrate an extensive array of public and private HIEs throughout the US; the fact that significant investment is occurring within both the public and private sectors speaks to the rapidly evolving market. Increased emphasis on advanced technologies such as cloud computing, artificial intelligence, and blockchain is being given to enable security and interoperability improvements for data systems as more healthcare organizations become conscious of the need for interconnected systems. Actually, the U.S. health information exchange industry is better poised to continue its growth in and around the future of healthcare delivery, one that is changing and further becoming efficient by its integration of collaboration among healthcare stakeholders. Recent developments include: In October 2022, Mpowered Health launched its xChange, the United States consumer-mediated healthcare data exchange. The exchange enables health plans, health systems, and other healthcare organizations to request and obtain medical records from consumers with their consent., In March 2022, mpro5 Inc announced its launch into the United States market with a strategy of enabling the collection and leverage of real-time data to simplify the most complex operational challenges in healthcare and hospitals.. Key drivers for this market are: Increasing Demand for Electronic Health Records Resulting in the Expansion of the Market, Government Support via Various Programs and Incentives; Reduction in Healthcare Cost and Improved Efficacy. Potential restraints include: Huge Initial Infrastructural Investment and Slow Return on Investment, Data Privacy and Security Concerns. Notable trends are: The Decentralized/Federated Model is Expected to Hold a Notable Market Share Over the Forecast Period.

The big data in healthcare market size is estimated to grow from USD 78 billion in 2024 to USD 540 billion by 2035, representing a CAGR of 19.20% till 2035

Editor’s Choice

• The global biopharmaceuticals market size is expected to be worth around USD 566 billion by 2032 from USD 263 billion in 2022, growing at a CAGR of 8.2% during the forecast period from 2022 to 2032.
• The overall success rate for phase I trials is around 16%, while for phase II trials it is around 10%. Phase III trials, which involve larger patient populations, have a success rate of around 25%.
• The average cost of bringing a new drug to market is projected to be around USD 2.6 billion.
• The National Genome Institute estimates that the cost of sequencing a human genome has fallen from around USD 100 million in 2001 to less than USD 1,000 in recent years.
• In 2020, WIPO received over 23,500 biotechnology-related patent applications, demonstrating the growing innovation and research in the field.
• The US biotechnology industry employed over 2.1 million people in 2020, including direct and indirect jobs.

(Source: Journal of Clinical Oncology, Journal of Health Economics, World Intellectual Property Organization, Biotechnology Innovation Organization)

Snapshot img

Artificial Intelligence (AI) Market in Healthcare Size 2025-2029

The artificial intelligence (AI) market in healthcare size is forecast to increase by USD 30.23 billion, at a CAGR of 33.1% between 2024 and 2029.

The market is experiencing significant growth, driven by the increasing demand for digitization in healthcare services. AI-based tools are increasingly being adopted to improve efficiency, accuracy, and patient outcomes in various healthcare applications. One of the most promising areas for AI in healthcare is elderly care, where these technologies can help address the growing population of aging individuals and their unique healthcare needs. However, the market faces challenges, including skepticism from physicians and providers regarding the reliability and effectiveness of AI solutions.
This reluctance can hinder the widespread adoption of AI in healthcare, necessitating efforts to build trust and demonstrate the tangible benefits of these technologies. Navigating these challenges will be crucial for companies seeking to capitalize on the market's potential and make a lasting impact on the strategic healthcare landscape.

What will be the Size of the Artificial Intelligence (AI) Market in Healthcare during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The market continues to evolve, with dynamic applications across various sectors. AI-powered diagnostics leverage machine learning algorithms and deep learning models for improved diagnostic accuracy, while ethics remain a critical consideration in their implementation. Robotic surgery and wearable sensors enhance patient care and enable remote monitoring, contributing to better outcomes and reduced medical errors. Personalized medicine and precision oncology benefit from data analytics platforms and big data management, facilitating early disease detection and drug discovery. Hospital information systems optimize workflows and ensure data integration, security, and privacy. Model validation and data validation are essential for maintaining model accuracy and reducing bias.

AI's role in mental health care and chronic disease management is increasingly significant, with computer vision systems and explainable AI facilitating image recognition and algorithm transparency. Telemedicine platforms and predictive analytics enable cost reduction and increased efficiency, while process optimization and risk stratification improve patient care. The ongoing unfolding of market activities includes the development of AI ethics frameworks, bias mitigation strategies, and data security measures. Natural language processing and data analytics platforms facilitate improved healthcare IT infrastructure, enabling more effective clinical decision support and patient privacy protection. Continuous advancements in AI technology and its integration into healthcare systems promise to revolutionize the industry, offering significant benefits for patients and healthcare providers alike.

How is this Artificial Intelligence (AI) in Healthcare Industry segmented?

The artificial intelligence (AI) in healthcare industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Application

  Medical imaging and diagnostics
  Drug discovery
  Virtual assistants
  Operations management
  Others


Component

  Software
  Hardware
  Services


End-user

  Hospitals and clinics
  Research institutes and academies


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan


  South America

    Brazil


  Rest of World (ROW)

By Application Insights

The medical imaging and diagnostics segment is estimated to witness significant growth during the forecast period.

Medical imaging, a crucial aspect of healthcare, involves creating visual representations of the human body for clinical analysis and diagnosis. Radiology, the science behind this process, encompasses techniques such as X-rays, CAT scans, and MRIs. However, managing vast amounts of high-resolution medical imaging data for effective treatment and diagnosis is a significant challenge for even large healthcare institutions and experienced professionals. The increasing volume of data and the need for radiologist efficiency have led to the adoption of Artificial Intelligence (AI) in medical imaging. AI technologies like natural language processing, machine learning algorithms, deep learning models, and image recognition are employed to enhance diagnostic accuracy, reduce medical errors, and improve efficiency.

Furthermore, AI aids in data integration, model

In 2021, the AI and machine learning medical device market was valued at around *** billion U.S. dollars globally. By 2032, the market was forecast to increase to a value of **** billion U.S. dollars.

Graph and download economic data for Labor Productivity for Health Care and Social Assistance: Medical and Diagnostic Laboratories (NAICS 62151) in the United States (IPURN62151L000000000) from 1994 to 2024 about diagnostic labs, healthcare, medical, social assistance, productivity, health, NAICS, IP, labor, and USA.

Note: This dataset is historical only and there are not corresponding datasets for more recent time periods. For that more-recent information, please visit the Chicago Health Atlas at https://chicagohealthatlas.org.

This dataset contains a selection of 27 indicators of public health significance by Chicago community area, with the most updated information available. The indicators are rates, percents, or other measures related to natality, mortality, infectious disease, lead poisoning, and economic status. See the full description at https://data.cityofchicago.org/api/assets/2107948F-357D-4ED7-ACC2-2E9266BBFFA2.